Josh Sandberg is the Chief Executive Officer of OrthoSpineNews. With a focus on the orthopedic and spine industry, Josh provides updates and insights on the latest advancements, product launches, acquisitions, and business developments in the field. His articles cover a wide range of topics, including case studies, financial updates, clinical trial results, and advancements in orthopedic technology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Josh Sandberg's coverage heavily focuses on the healthcare and pharmaceutical industry, particularly within the orthopedic sector. His articles predominantly feature press releases and private sector announcements related to medical devices, FDA clearances, company updates, and healthcare mergers.
Given his focus on these topics and themes, he is likely to be interested in pitches that provide valuable insights into new medical devices or technologies entering the market, regulatory changes affecting the orthopedic industry, major company developments such as mergers or acquisitions within this space.
Pitching sources with insider knowledge of these areas or those who can offer unique perspectives on industry trends could significantly increase your chances of successfully reaching out to Josh. Keep in mind that while there is no specific geographic focus mentioned for Josh Sandberg's coverage attributes are not limited by region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Josh Sandberg
TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ — This announcement is a summary of Bioretec Ltd’s half-year report January-June 2024. The complete half-year report with tables is attached to this release as a pdf file and available at the company’s web pages at https://bioretec/investors/investors-in-english/releases. April-June 2024 in brief Net sales increased by 68% and amounted to EUR 1,379 thousand (4-6/2023: EUR 820 thousand). Sales …
By: Josh Sandberg
GALWAY, Ireland, Aug. 16, 2024 /PRNewswire/ — The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 15, 2024, approved the company’s cash dividend for the second quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of the S&P 500 …
Surgery Partners is the third-largest ASC operator in the country, and private equity firms are reportedly also interested in buying the chain.
The two organizations contend that their combined strengths will help to advance the level of care for patients in New York and Connecticut. (Photo Credit Northwell Health) August 28, 2024 – Jeff Lagasse, Editor – Attorneys general from Connecticut and New York have given their blessing to a 28-hospital merger proposed by Northwell Health and Nuvance …
By: Josh Sandberg
WARSAW, Ind., Aug. 29, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2024. The cash dividend of $0.24 per share is payable on or about October 31, 2024 to stockholders of …
By: Josh Sandberg
Company’s industry-first technology addresses chronic low back pain Aclarion secured its first commercial agreement with Michigan’s Sheridan Community Hospital PRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — PRISM MarketView, a leading provider of market insights and company news, is …
By: Josh Sandberg
Ushers in a new era where surgery is no longer a one-off event but an opportunity to gather data to radically improve the practice of surgery and its role in the healthcare economy. SEATTLE, Sept. 10, 2024 /PRNewswire/ — Proprio, the global leader in AI-powered surgical technology, announced today that its innovative surgical guidance platform, Paradigm, has reached a …
By: Josh Sandberg
NanoBone® is a next-generation osteoinductive bone graft consisting of patented nanostructured hydroxyapatite for remodelling bone Biocomposites to introduce NanoBone at the British Orthopaedic Association’s Annual Congress in Birmingham KEELE, England, Sept. 12, 2024 /PRNewswire/ — Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft …
By: Josh Sandberg
Walgreens allegedly billed the government for prescriptions never dispensed, says DOJ. September 16, 2024 – Susan Morse, Executive Editor – Walgreens has agreed to pay $106.8 million to resolve allegations that it billed the government for prescriptions never dispensed, according to the Department of Justice. The government alleges that, between 2009 and 2020, Walgreens submitted false …
By: Josh Sandberg
HELP Committee will vote Thursday on Contempt Resolutions for civil enforcement and criminal contempt. September 17, 2024 – Susan Morse, Executive Editor – The Senate Help, Education, Labor & Pensions Committee is scheduled to meet in an executive session on Thursday at 10 a.m. ET on a Contempt Resolution against Steward Health CEO Dr. Ralph de la Torre. HELP …
(833) 317-6278 
